Celgosivir

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameCelgosivir
Drug Alias Name西戈斯韦Celgosivirum6-O-ButanoylcastanospermineBuCastMDL 28574A +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcidic alpha-glucosidase inhibitors
TargetsAcidic alpha-glucosidase
Therapy Area/IndicationsHepatitis C, ChronicDengueHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator Companies60 Degrees Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies60 Degrees Pharmaceuticals LlcHoechst Marion Roussel LtdDuke-Nus Medical School +[4] 
Active IndicationsN/A
Inactive IndicationsHepatitis C, ChronicDengueHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG